Full-Time

Director – Operations Optimization and Automation

Confirmed live in the last 24 hours

R1 RCM

R1 RCM

10,001+ employees

Revenue cycle management solutions for healthcare

Compensation Overview

$112.2k - $167.6k/yr

+ Bonus

Senior, Expert

Utah, USA

Category
Quality Control & Compliance
Supply Chain Management
Operations & Logistics
Required Skills
Data Analysis
Requirements
  • Experience with automation and optimization
  • Previous revenue cycle leadership work experience in a Director-level role
  • Exceptional organizational skills to manage complex changes
  • Process-oriented with a critical eye for detail
  • Self-motivated and pragmatic
  • Team player who is analytical and solution-focused
  • Background in working with 835 data, various payment methodologies, and accounting systems
Responsibilities
  • Oversee and coordinate revenue enhancement initiatives and business operations across all aspects of the revenue cycle for client hospitals
  • Partner with Executive-level client counterparts to align operational objectives
  • Translate industry expertise into a strategic vision and generate client buy-in
  • Lead, coach, and develop a team of local 2-4 direct reports
  • Drive team performance to high achievement and high-quality outcomes
  • Participate in Accretive strategy development as a thought leader and content expert
  • Focus on development, performance and growth of direct reports
  • Own all management decisions regarding daily operations within assigned hospital(s)
  • Work with client C-suite and CFO collaboratively to drive results
  • Gain executive client buy-in for intricate projects and initiatives

R1 RCM provides Revenue Cycle Management (RCM) solutions to healthcare providers, including hospitals and physician groups. The company uses technology to streamline financial and administrative processes, helping clients manage patient service revenue more effectively. R1 RCM stands out by focusing on reducing administrative burdens, allowing healthcare providers to prioritize patient care. The goal is to enhance patient experiences and improve financial outcomes for healthcare organizations.

Company Size

10,001+

Company Stage

IPO

Headquarters

Murray, Utah

Founded

2003

Simplify Jobs

Simplify's Take

What believers are saying

  • R1's partnership with Palantir enhances AI capabilities for efficient revenue cycle management.
  • The $8.9B acquisition provides financial backing for technology investment and expansion.
  • The RCM market is projected to reach $367.7 billion by 2031, offering growth opportunities.

What critics are saying

  • Inconsistencies in turnaround times and accuracy could affect client satisfaction.
  • The acquisition may lead to strategic shifts disrupting operations or employee morale.
  • Competitors like Xsolis pose a threat to R1 RCM's market position.

What makes R1 RCM unique

  • R1 RCM specializes in end-to-end Revenue Cycle Management for healthcare providers.
  • The company leverages advanced technology to streamline financial and administrative processes.
  • R1 RCM's solutions focus on improving patient experience and financial performance.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Business Wire
Mar 14th, 2025
R1 Launches 'R37': An AI Lab to Transform Healthcare Financial Performance in Exclusive Partnership with Palantir

By integrating Palantir's AI tools and capabilities with R1's existing technology and domain expertise, R37 can unlock faster, more precise scalable reimbursement outcomes.

ETF Daily News
Dec 16th, 2024
EP Wealth Advisors LLC Makes New $168,000 Investment in R1 RCM Inc. (NASDAQ:RCM)

EP Wealth Advisors LLC makes new $168,000 investment in R1 RCM Inc. (NASDAQ:RCM).

Hit Consultant
Nov 21st, 2024
Xsolis Leads In Client Satisfaction For Physician Advisory Services, Klas Report Finds

What You Should Know:– A new KLAS Research report examines the key drivers of client satisfaction in the physician advisory services market, highlighting the importance of accuracy, timeliness, strong relationships, and specialized service lines.– KLAS names Xsolis as a leader in overall client satisfaction among physician advisory services firms in helping healthcare providers navigate the complexities of regulatory and payer requirements.Key Drivers of Client SatisfactionThe report identifies several key factors that drive client satisfaction with physician advisory services:Accuracy: Providers value accurate and reliable determinations from physician advisors.Providers value accurate and reliable determinations from physician advisors. Timeliness: Prompt turnaround times for case reviews are essential for efficient workflows.Prompt turnaround times for case reviews are essential for efficient workflows. Clear Explanations: Providers appreciate clear, concise, and detailed explanations of determinations, which can be crucial for appeals if needed.Providers appreciate clear, concise, and detailed explanations of determinations, which can be crucial for appeals if needed. Strong Relationships: Building strong relationships and trust between providers and physician advisory firms is essential for effective collaboration.Report Key FindingsXsolis stands out for its high client satisfaction scores, particularly in the areas of accuracy, timeliness, and clear explanations. Clients praise the expertise of Xsolis’ physician advisors and the comprehensive documentation provided.The report also examines other leading physician advisory services firms, including R1 RCM, Brundage Medical Group, and Sound Physicians. Each firm has its own strengths and areas for improvement, highlighting the diverse landscape of this market.R1 RCM: Clients appreciate the comprehensive documentation and summaries provided by R1 RCM, but some report inconsistencies in turnaround times and accuracy, potentially due to high case volumes.Brundage Medical Group: Clients value the firm’s quick response rates and comprehensive explanations, which have led to positive outcomes like increased payer payments and improved CMS Star ratings

Stock Titan
Nov 19th, 2024
R1 RCM $8.9B Buyout, CEO Returns

R1 RCM has been acquired by TowerBrook Capital Partners and Clayton, Dubilier & Rice in a deal valued at approximately $8.9 billion. The acquisition, announced on August 1, 2024, involved purchasing all outstanding shares at $14.30 per share in cash. Following the transaction, R1 RCM is now a private company and has ceased trading on Nasdaq. Joe Flanagan has returned as CEO, replacing Lee Rivas, to focus on operational excellence and technology leadership.

Hit Consultant
Oct 16th, 2024
Hlth 2024: 21 Executives Share Their Predictions And Insights

As HLTH 2024 prepares to convene in Las Vegas, the anticipation for groundbreaking insights and transformative discussions is palpable. To get a glimpse into the key themes and predictions shaping this year’s event, we reached out to 21 digital health executives for their expert perspectives.From the rise of generative AI and the evolving role of virtual care to the increasing focus on health equity and value-based care, these industry leaders offer a diverse range of perspectives on the most pressing challenges and promising opportunities facing the healthcare ecosystem.Join us as we delve into their predictions and explore the trends that are poised to redefine the future of healthcare at HLTH 2024.Ryne Natzke, chief revenue officer, TrustCommerce, a Sphere company, a provider of end-to-end integrated healthcare payments and security softwareAI, AI, and more AI! I’m looking forward to seeing how AI is being applied to help clinicians, patients, and other staff members provide better patient experiences and outcomes. Everything is moving so quickly that it will be exciting to get an update on where the industry is going.James Aita, director, Strategy and Business Development, Medicomp Systems, a physician-driven provider of diagnostically connected patient data solutionsOf course AI is the hot topic at HLTH this year–but with the new regulations from ASTP/ONC, the question is how can it be usable, trustworthy, transparent and helpful. I’m also interested in seeing who else is making AI and clinical data helpful at the point of care to reduce the burden on clinicians and inform patient care.Lyle Berkowitz, MD, CEO, KeyCare, the nation’s first Epic-based virtual care companyI always look forward to HLTH and seeing presentations of the newest cutting-edge technology and ideas. This year, I’m expecting deeper and wider use cases of AI to lead the charge. But in addition to technology innovations, I’m also hoping we will hear about other people and process topics such as how to set up virtual care teams and how to rethink primary care physician compensation to better align around adoption of automation and team-based care.Kazu Okuda, MD, CEO and co-founder of Universal Brain, whose platforms use brain-function measurement to drive precision psychiatryThe emergence of personalized treatment is an exciting field that I expect to take center stage at HLTH this year